Trial
NCT03126461
SAbR Plus Ipilimumab Plus Nivolumab in Metastatic Melanoma Patients
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
—
Condition
Melanoma
Intervention
SAbR
Why stopped
the project was never initiated and no participants were enrolled, it was closed permanently
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-20